MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
PerkinElmer EV 2011-2026 | PKI
EV Jährlich PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 B | 17.7 B | 20.2 B | 21.6 B | 23 B | - | 14.3 B | 12.9 B | 7.74 B | 7.17 B | - | 6.86 B | 6.57 B | 4.53 B | 9.47 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 23 B | 4 B | 12 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 17.95 | -1.97 % | $ 957 M |  USA |
 |
Agilent Technologies
A
|
45.8 B | $ 115.26 | -0.19 % | $ 35 B | USA |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 166.68 | -4.15 % | $ 8.26 B | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 25.08 | 0.95 % | $ 697 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Danaher Corporation
DHR
|
145 B | $ 191.97 | 0.44 % | $ 137 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
DexCom
DXCM
|
28.2 B | $ 62.95 | 1.17 % | $ 24.6 B | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Fulgent Genetics
FLGT
|
502 M | $ 16.54 | -1.66 % | $ 500 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
15.2 B | $ 90.17 | -3.9 % | $ 11.3 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.03 | -1.06 % | $ 173 M |  China |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 110.02 | -3.65 % | $ 9.07 B |  Irlanda |
 |
Illumina
ILMN
|
15.3 B | $ 127.46 | 0.06 % | $ 20.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 170.2 | -1.77 % | $ 29.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 274.39 | 0.24 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 76.15 | 0.07 % | $ 5.14 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 496.01 | -0.47 % | $ 14.3 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 265.73 | 0.46 % | $ 26.1 B |  Schweiz |
 |
ENDRA Life Sciences
NDRA
|
4.49 M | $ 4.56 | -2.72 % | $ 3.59 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 7.94 | -0.73 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.46 | 0.53 % | $ 2.05 B | USA |
 |
National Research Corporation
NRC
|
432 M | $ 17.42 | 1.52 % | $ 390 M | USA |
|
Biodesix
BDSX
|
142 M | $ 15.96 | 5.91 % | $ 2.07 B | USA |
 |
Natera
NTRA
|
5.53 B | $ 204.3 | -1.77 % | $ 20.1 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.42 | 5.6 % | $ 426 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 27.17 | 0.2 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
42.5 M | $ 26.25 | 3.35 % | $ 42.1 M | USA |
 |
Personalis
PSNL
|
229 M | $ 6.59 | 0.15 % | $ 390 M | USA |
 |
RadNet
RDNT
|
7.26 B | $ 55.09 | 0.55 % | $ 4.14 B | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.81 | -1.3 % | $ 284 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Sotera Health Company
SHC
|
7.07 B | $ 14.86 | -0.67 % | $ 4.22 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.3 | 32.43 % | $ 2.66 B | USA |
 |
Neuronetics
STIM
|
168 M | $ 1.79 | 17.76 % | $ 118 M | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 485.83 | -1.15 % | $ 183 B | USA |